L&K Biomed Ltd. (KOSDAQ:156100)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,985.00
-5.00 (-0.13%)
At close: Jul 28, 2026

L&K Biomed Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
8,9763,1783,8355,0477,39516,108
Short-Term Investments
17,6083,10816,1087,7295,6083,108
Cash & Short-Term Investments
26,5846,28619,94312,77613,00319,216
Cash Growth
48.14%-68.48%56.10%-1.75%-32.33%133.88%
Accounts Receivable
19,84617,91214,9809,8395,7801,526
Other Receivables
1,144739.65290.261,066223.05635.92
Receivables
20,99018,93316,01510,9056,0032,162
Inventory
37,85734,65824,55119,08916,36613,856
Prepaid Expenses
618.24680.38525.95656.55444.63688.1
Other Current Assets
1,358612.062,532990.85330.622,042
Total Current Assets
87,40761,17063,56644,41736,14737,964
Property, Plant & Equipment
12,5779,61710,0059,0128,5149,271
Long-Term Investments
644.53644.53577.51,04964.151,203
Other Intangible Assets
1,1251,059998.17798.73715.111,209
Long-Term Accounts Receivable
3,4614,1401,8071,2812,3855,200
Long-Term Deferred Tax Assets
5,0835,2775,0095,5163,9023,591
Long-Term Deferred Charges
----106.09223.63
Other Long-Term Assets
1,4051,375798.55387.38829.96623.29
Total Assets
111,70283,48383,06162,76252,66359,285

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
2,7323,7813,3472,0472,437498.73
Accrued Expenses
1,441963.43851.44685.87589.86606.95
Short-Term Debt
23,93515,27920,55810,04020,4066,692
Current Portion of Long-Term Debt
1,1001,1008001002,800-
Current Portion of Leases
531.34706.84669.07828.69750.57636.63
Current Income Taxes Payable
207.17205.087.290.3554.090.89
Other Current Liabilities
23,50116,29612,8419,06210,9434,177
Total Current Liabilities
53,44838,33239,07422,76337,98112,613
Long-Term Debt
5005001,0001,700-13,608
Long-Term Leases
1,4311,562369.63845.161,2441,518
Pension & Post-Retirement Benefits
3,2493,1193,0572,2321,5741,330
Long-Term Deferred Tax Liabilities
1,1421,2161,5691,3611,047-
Other Long-Term Liabilities
124.77118.911,9583,27455.375,429
Total Liabilities
59,89444,84847,02832,17541,90234,499

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
11,17610,8939,9689,9686,7036,696
Additional Paid-In Capital
80,37773,69290,38690,38668,17467,992
Retained Earnings
-32,539-40,867-58,746-67,849-65,348-51,884
Treasury Stock
-0.09-0.09-0.09-0.09-0.09-0.09
Comprehensive Income & Other
271.021,759887.932,8462,7401,663
Total Common Equity
59,28445,47742,49635,35112,26824,467
Minority Interest
-7,477-6,842-6,463-4,764-1,507319.82
Shareholders' Equity
51,80838,63536,03330,58710,76224,787
Total Liabilities & Equity
111,70283,48383,06162,76252,66359,285

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
27,49719,14823,39713,51325,20122,456
Net Cash (Debt)
-912.93-12,861-3,454-737.76-12,198-3,240
Net Cash Growth
------
Net Cash Per Share
-43.79-632.68-158.80-45.50-910.57-242.05
Filing Date Shares Outstanding
22.3521.7919.9419.9413.4113.39
Total Common Shares Outstanding
22.3521.7919.9419.9413.4113.39
Working Capital
33,95822,83824,49221,654-1,83425,351
Book Value Per Share
2652.402087.382131.561773.17915.171826.89
Tangible Book Value
58,16044,41841,49834,55311,55323,258
Tangible Book Value Per Share
2602.082038.782081.501733.11861.821736.61
Land
2,594737.02737.02737.02737.02737.02
Buildings
3,3732,5022,5022,5022,5022,502
Machinery
16,35316,00616,49114,30712,33011,671
Construction In Progress
-2559---